All News

Michael Frank, CEO of Revive Therapeutics, and Derrick Welsh, COO of Psilocin Pharma, a division of Revive Therapeutics, discuss clinical research investigating novel treatment targets for psilocybin, such as treatment-resistant depression in patients with cancer.

Pharmacy Times spoke with Dr. Jeffrey Akers, CEO of Pharmaceutical Services at Appalachian Regional Healthcare, about how integrated technology can empower pharmacists to prioritize patient care and safety and can help prevent harmful medication events from occurring.

Although October has long been celebrated as National Pharmacy Month, it is only in recent years that female pharmacists have been celebrated for their contributions to the profession and patient care.

The authors said stigmatization threatens societal cohesion during times of national upheaval, such as during a pandemic.

Jameshia Below, PharmD, assistant professor of pharmacy practice at the University of Louisiana Monroe College of Pharmacy, explains how oncologic emergencies present in patients, and how each type can be recognized.

October 12 observance gives special recognition to the significant achievements made.

Patients receiving sacituzumab govitecan also reported lower symptomatic impact of fatigue, pain, dyspnea, and insomnia.

Biotin deficiency can cause thinning of the hair and a rash on the face.

Evolocumab is a PCSK9 inhibitor indicated to reduce the risk of myocardial infarction, stroke, and coronary revascularization in adults with established cardiovascular disease.

People who inherit familial hypercholesterolemia from both parents usually develop symptoms in childhood.

Fluciclovine F 18 (Axumin), which is a radioactive diagnostic agent for injection that can be used to detect recurring prostate cancer.

AbbVie announced positive top-line results from a phase 3 trial for the efficacy and safety of upadacitinib for individuals with the rheumatic disease.

The PROpel phase 3 trial met the primary endpoints of radiographic progressing-free for men with metastatic castration-resistant prostate when treated with Olaparib, combined with abiraterone.

The medication, which has been cleared as a treatment for the inflammatory disease of the throat, is under priority review by the agency.

There are 3 PARP inhibitors that are FDA approved in multiple settings of ovarian cancer.

The study aimed to examine the impact of masking and social distancing practices used to control the spread of COVID-19.

The majority of treatment-related adverse events (TRAEs) were grade 1-2 in severity, and no patients experienced dose-limiting toxicities during the 28 days following initial treatment.

The researchers used a body composition analysis of patients with Crohn disease in a collaboration with gastroenterology and surgical specialists.

The study also failed to meet its secondary efficacy endpoints and no new safety signals were observed.

Allostatic load is caused by a number of different stressors, including social isolation, poverty, and racism, many of which are commonly experienced by individuals belonging to racial and ethnic minorities, according to the investigators.

The Pharmacy Times® Pharmacy Focus podcast provides the latest industry news and information, thought-leader insights, clinical updates, patient counseling tools, and innovative solutions for the everyday practice and business of pharmacy.

Zyrtec is an antihistamine with principal effects mediated via selective inhibition of peripheral H1 receptors.

Semaglutide acts as a GLP-1 receptor agonist that selectively binds to and activates the GLP-1 receptor.

Types of seizure include focal seizures with impaired awareness, generalized seizures without loss of consciousness, and generalized seizures, such as absence seizures.

The medication has both short- and long-term effects on improving excessive sleepiness.

The most common medication errors seen in LTC facilities include dispensing errors, delay in delivery, and expired inventory.

Patients with cancer should not be overlooked in any pharmacy setting. These patients are in need of resources, help, and hope.

There is a real opportunity for technology to alleviate some of the administrative burdens pharmacists face so that they have more time to focus on patient care.

Samples for the test are isolated from nasopharyngeal swabs, anterior nasal swabs, and mid-turbinate swabs.

The paper reviews the safety profile of solriamfetol in treating ES associated with OSA or narcolepsy and discusses subject areas such as pharmacology, clinical efficacy, and tolerability of the drug.